ProPhase Labs (PRPH) Competitor Comparison
We are evaluating the key criteria listed to compare ProPhase Labs (PRPH) against its competitors in the Drug Manufacturers - Specialty & Generic industry.
Market Capitalization
40 / 54Gross Profits
25 / 39Total Revenue
41 / 50EBITDA
37 / 53Free Cashflow
36 / 54Quick Ratio
15 / 54Earnings per Share
35 / 54Dividend yield
0 / 5Total Cash
54 / 54Performance 3 years
44 / 54Performance 5 years
29 / 54Performance 10 years
21 / 54Linearity 3 years
14 / 54Linearity 5 years
4 / 54Linearity 10 years
2 / 54Total Rank
1 / 54Dividend Rank
3 / 54Valuation Rank
9 / 54Piotroski Rank
14 / 54Muliplier Rank
5 / 54Piotroski Rank - PRPH ranking 14 / 54
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.